Background
==========

Historically, injection drug use, mainly heroin, was concentrated in the rural areas of southwestern and northwestern China, and has been the major contributor to the HIV/AIDS epidemic in this country \[[@B1]-[@B3]\]. However, in recent years, China has seen an upsurge in club drug use, especially methamphetamine, which is quickly replacing heroin to become the most widespread illicit drug across the nation \[[@B4]-[@B7]\]. Shandong is one of the provinces confronting the rapidly emerging club drug use. One of the cities along the east coast has been named the "ice city", for its common use of club drugs, especially among young people. MA and other club drugs are often used in entertainment venue settings, such as hotels, Bars, KTV and tea houses. Club drugs were perceived as a pastime, an entertainment additive without any stigma attached to it, rather than the highly stigmatized traditional substance abuse. Methamphetamine can be smoked, snorted, injected or orally ingested. These drugs meet the psychological characteristics of young people, e.g., curiosity, wonder, and excitement \[[@B8],[@B9]\]. Synthetic drug use fuels the transmission of HIV/other STDs (sexually transmitted diseases) \[[@B10],[@B11]\]. Empirical studies from other countries have demonstrated an association between synthetic drug use and risky sexual behaviors that include unprotected anal and vaginal intercourse, and sexual activities with multiple partners, as well as an association between club drug use and HIV/other STDs \[[@B12]-[@B15]\]. Among the 780,000 estimated HIV/AIDS cases in 2011, 63.9% were infected through sexual transmission, and 17.4% through male-to-male contact, which has emerged as one of the major transmission routes in China \[[@B16]\]. New types of drugs, termed synthetic drugs or club drug users, could play a significant role in fueling the epidemics of HIV and other STDs without an effective action taken in a timely fashion \[[@B7],[@B17]\].

China faces the emerging syndemics of HIV, other STDs, and synthetic drugs \[[@B18],[@B19]\]. Studies have been conducted focusing on HIV and other STDs, however, the research on club drugs and its impact on HIV and other STDs remains scarce. Both the extent of the epidemic of club drug use and its social consequences are not yet fully recognized \[[@B17]\]. Limited information is available on the syndemics of HIV/other STDs, Hepatitis C Virus (HCV), and club drugs in China \[[@B20]\]. This study investigated the type of drugs, syphilis and hepatitis C virus (HCV) infection and the correlates for syphilis, HCV and unprotected commercial sex behavior among drug users in Jining City and Qingdao City, Shandong Province of China.

Methods
=======

Recruitments and participants
-----------------------------

A cross-sectional survey was conducted in Jining and Qingdao, Shandong Province in 2010. Prior to the recruitment of the participants of the survey, we conducted informative research including in-depth interviews with key informants to gather the background information among drug users, e.g., the venues to access them, selection of the candidates of the first group for interview, and sampling frame. All potential participants were invited for an eligibility assessment. Recruitment criteria required that participants be willing to complete the study, and self-report having used drugs in the last year. Participants were approached from drug user gathering venues such as bars, night clubs, bathhouses, saunas, public parks, outdoor cruising areas, and HIV testing sites. After these initial participants were approached and interviewed after an eligibility assessment, we asked the participants to refer their peers to attend the study. A mixed recruitment method, including community outreach, venue-based recruitment, and peer referrals, was applied in the study. Structured questionnaire based interviews were conducted by trained health professionals in a carefully selected clinic in each city. Voluntary participation, anonymity and confidentiality were ensured for all participants. The trained interviewer also conducted some of the interviews within the community or venues such as hotels or bars because some of the participants were not willing to visit the clinics. The experienced study staff explained the study purpose and protocol including voluntary and anonymity of participation, confidentiality and security of data collection, and safety of blood sample collection to all potential participants. An informed consent was received from all eligible participants. The study was approved by the Institutional Review Board (IRB) of Shandong Center for Disease Control and Prevention.

Measures
--------

Questionnaire-based interviews provided information including demographics (age, marital status, ethnicity, residency, education), sexual and drug use behaviors (sex behavior with regular and commercial partners, condom use with clients or regular sex partners, types of drug use and injection history), HIV knowledge, HIV testing, and HIV-related prevention services. Participants who reported using various types of drugs in the last year were defined as methamphetamine, heroin, cocaine, cannabis, morphine, pethidine, ketamine, MAMD (Ecstasy), and amphetamine users. The regular sex partner refers to their spouse if married or the sex partners that are not married but live together.

Level of HIV knowledge was assessed using eight questions regarding the modes of HIV transmission and prevention, as well as misperception. All questions were weighted equally. Responses to these questions were combined into an overall score for each of the correct and incorrect answers. These scores were then stratified into two groups, according to whether six or more appropriate responses were given to the eight questions. The use of HIV-related prevention services was assessed by whether participants had ever received one of the five indicators related to relevant prevention services in the past 12 months (peer education, HIV counseling and testing, community drug maintenance treatment, needle and syringe provision & exchange, or received free condoms).

Blood samples were collected and tested for HIV, syphilis and HCV. Two screening tests were used to diagnose HIV: an enzyme-linked immunosorbent assay and a confirmatory test using the HIV-1/2 Western Blot immune assay (HIV Blot 2.2 WB; Genelabs Diagnostics, Singapore). Syphilis was diagnosed using rapid plasma reagin (RPR^TM^) and a Passive Particle Agglutination Test for Detection of Antibodies to Treponema pallidum (TPPA^TM^, Rong Sheng Biostix Inc, Shanghai, China). Two screening tests using an enzyme-linked immunoassay (Beijing Wantai Biological Medicine Company, China and Xiamen Xinchuang Industrial Scientific, China) were performed to determine HCV status. All of the participants were informed of their testing results of HIV, syphilis and HCV by trained health professionals. All of the notification of testing results and referrals for positive individuals to subsequent prevention, counseling, and treatment services were also provided in a confidential manner using a prior signed unique code.

Statistical analyses
--------------------

Questionnaire-based data and biological results were recorded into the EpiData software (EpiData 3.0 for Windows, the EpiDate Association Odense, Denmark). All analyses were performed with the SPSS® software (Version 15.0; SPSS Inc., Chicago, Illinois, USA). The prevalence rates of syphilis, HCV and unprotected sex were calculated by demographic characteristics, drug use and sexual behaviors, and utilization of HIV-related prevention services. Univariate analyses were performed for the independent variables of demographic, behavioral, and biological variables. A multivariable logistic regression model was constructed. Both adjusted odds ratios (AOR) and 95% confidence intervals (CIs) were calculated for each explanatory variable in the final models. All potential co-linearity, potential confounding, and effect modification were examined and taken into consideration in the final models. Statistical significance for the variables was determined with p \< 0.05 in the model.

Results
=======

Characteristics of participants
-------------------------------

Of 805 eligible participants, 82.8% were male; 28.0% single, 70.2% currently married or cohabitating; the median age was 30 years with a range from 16 to 67 years; 86.5% were local residents; 64.2% received middle school or a lower level of education; only 3.6% belonged to non-Han ethnic groups; 66.8% correctly answered at least 6 out of 8 questions on HIV transmission, prevention and misperceptions; 16.1% received HIV-related intervention in the past 12 months; 4.7% had a test for HIV in the past 12 months while 52.6% knew their HIV test result (Table  [1](#T1){ref-type="table"}).

###### 

Demographic characteristics, drug use and sexual behaviors, and utilization of HIV-related prevention services among club drug users in Shandong Province, China

  **Factors**                                                   **Participants**   **Syphilis**     **HCV**     **Unprotected sex\***                    
  ------------------------------------------------------------ ------------------ -------------- ------------- ----------------------- ---- ------ ----- ------
  **Age (years;**$\left. \overline{x} \pm {SD} \right)$             30 ± 9.1       32.1 ± 11.4    29.8 ± 10.1        29.9 ± 9.2                          
   ≥18                                                                285              35.4           27                 9.5            11   3.9    72    49.0
   25-35                                                              281              34.9           20                 7.1            11   3.9    62    44.9
   35-45                                                              183              22.7           21                11.5            6    3.3    57    54.3
   ≥45                                                                 56              7.0             9                16.1            2    3.6    20    60.6
  **Gender**                                                                                                                                                
   Male                                                               662              82.2           52                 7.9            26   3.9    176   37.6
   Female                                                             143              17.8           25                17.5            4    2.8    35    53.3
  **Marital status**                                                                                                                                        
   Single                                                             225              28.0           21                 9.3            9    4.0    67    47.2
   Married or cohabiting                                              565              70.2           52                 9.2            20   3.5    139   51.5
   Divorced or widowed                                                 15              1.8             4                26.7            1    6.7     5    45.5
  **Education**                                                                                                                                             
   Middle school or lower                                             517              64.2           49                 9.5            15   2.9    179   58.5
   High school or higher                                              288              35.8           28                 9.7            15   5.2    32    27.4
  **Types of drugs**^**\#**^                                                                                                                                
   Heroin                                                              26              3.2             0                 0.0            3    11.5    2    28.6
   Cocaine                                                             1               0.1             0                 0.0            0    0.0     1    100
   Opium                                                               0                0              0                 0.0            0    0.0     0     0
   Cannabis                                                            4               0.5             0                 0.0            0    0.0     1    33.3
   Morphine                                                            1               0.1             0                 0.0            0    0.0     0     0
   Methamphetamine                                                    778              96.6           77                 9.9            28   3.6    207   49.9
   Pethidine                                                           0                0              0                 0.0            0    0.0     0     0
   Ketamine                                                            51              6.3             1                 2.0            2    3.9     2    28.6
   MAMD                                                                36              4.5             0                 0.0            0    0.0     1    20.0
   Amphetamine                                                         32              4.0             1                 3.1            3    9.4     2    40.0
  **Multi-drug use (types)**                                                                                                                                
   \<2                                                                709              88.1           75                10.6            25   3.5    208   51.0
   ≥2                                                                  96              11.9            2                 2.1            5    5.2     3    20.0
  **Had ever injected**                                                                                                                                     
   Yes                                                                 92              11.4            8                 8.7            9    9.8    11    44.0
   No                                                                 713              88.6           69                 9.7            21   2.9    200   50.3
  **Had ever sex with regular sex partners in last year**                                                                                                
   Yes                                                                558              98.8           49                 8.8            20   3.6    138   51.9
   No                                                                  7               1.2             3                42.9            0    0.0     1    25.0
  **Condom use with regular sex partners in last year**                                                                                                  
   Always                                                              21              3.8             0                 0.0            1    4.8     0     0
   Sometimes                                                          120              21.5            6                 5.0            2    1.7     4    11.4
   Never                                                              417              74.7           43                10.3            17   4.1    134   58.8
  **Condom use with regular sex partners in last sex**                                                                                                   
   Yes                                                                 41              7.3             1                 2.4            1    2.4     0     0
   No                                                                 517              92.7           49                 8.8            19   3.7    138   54.5
  **Had ever sex with commercial sex partners in last year**                                                                                             
   Yes                                                                423              52.5           49                11.6            13   3.1    \-     \-
   No                                                                 382              47.5           28                 7.3            17   4.5    \-     \-
  **Condom use with commercial sex partners in last year**                                                                                               
   Always                                                              43              10.1            2                 4.7            1    2.3    \-     \-
   Sometimes                                                          169              40.0           23                13.6            3    1.8    \-     \-
   Never                                                              211              49.9           24                11.4            3    1.4    \-     \-
  **Condom use with commercial sex partners in last sex**                                                                                                
   Yes                                                                105              24.8            6                 5.7            3    2.9    \-     \-
   No                                                                 318              75.2           43                13.5            4    1.3    \-     \-
  **Ever received intervention**                                                                                                                         
   Yes                                                                130              16.1           14                10.8            5    3.8    29    34.1
   No                                                                 675              83.9           63                 9.3            25   3.7    182   53.8
  **Syphilis/HCV infection**                                                                                                                                
   Syphilis Positive                                                   77              9.6            \-                 \-             11   14.3   24    56.2
   HCV Positive                                                        30              3.7            11                36.7            \-    \-     3    42.9
   Syphilis/HCV Negative                                              709              88.1           \-                 \-             \-    \-    186   26.2
  **HIV knowledge score**                                                                                                                                   
   Score\<6                                                           267              33.2           31                11.6            7    2.6    155   72.1
   Score ≥ 6                                                          538              66.8           46                 8.6            23   4.3    56    26.9

Subtotals do not add up to 100% for some variables because of missing values.

\*Unprotected sex means no condom use with commercial sex partners in the last year.

^**\#**^The factor of "types of drugs" was multi-choice variables, the percentages will not add up to 100%.

Drug use, sexual behaviors and correlates for unprotected sex
-------------------------------------------------------------

Of the participants, 96.6% (n=778) were methamphetamine users, 6.3% (n=51) ketamine users, 4.5% (n=36) MAMD users, 4.0% (n=32) amphetamine users and 3.2% (n=26) heroin users. Of the participants, 11.9% (n=96) reported having ever used ≥2 types of these drugs and 11.4% (n=92) reported having ever injected drugs. Of the participants, 98.8% reported ever having sex with regular sex partners, with 74.7% never having used condoms in the past 12 months and 92.7% reporting no condom use in the last sexual encounter. 52.5% of participants reported having commercial sex, with 89.9% reporting inconsistent condom use in the past 12 months and 75.2% reporting no condom use in the last sexual encounter (Table  [1](#T1){ref-type="table"}). Participants who have ever had unprotected sex with commercial sex partners in the last sexual encounter were more likely to be female, have received middle school or a lower level of education, have never received an intervention in the last year and be infected with syphilis (Table  [2](#T2){ref-type="table"}).

###### 

Factors associated with syphilis and HCV infection among club drug users in Shandong, China

  **Factors**                                                   **Syphilis infection(n**=**77)**   **HCV infection (n**=**30)**   **Unprotected sex**                                                                           
  ------------------------------------------------------------ ---------------------------------- ------------------------------ --------------------- ------ ------------------- ------------------- ------ ------------------ ------------------
  **Gender**                                                                                                                                                                                                                             
   Male                                                                       7.9                              1.0                        1.0           3.9           1.0                              37.6         1.0                1.0
   Female                                                                     17.5                       2.5(1.5-4.2)\*\*           2.8(1.2-6.5)\*      2.8      0.7(0.2-2.0)                          53.3   3.0(1.8-5.1)\*\*   2.9(1.7-4.9)\*\*
  **Education**                                                                                                                                                                                                                          
   Middle school or lower                                                     9.5                              1.0                                      2.9           1.0                              58.5   3.7(2.3-5.9)\*\*   3.4(2.0-5.5)\*\*
   High school or higher                                                      9.7                          1.0(0.6-1.7)                                 5.2      1.8(0.9-3.8)                          27.4         1.0                1.0
  **Had ever injected**                                                                                                                                                                                                         
   Yes                                                                        8.7                          0.9(0.4-1.9)                                 9.8    3.6(1.6-8.1)\*\*     2.7(1.1-6.5)\*     44.0     0.8(0.4-1.7)             
   No                                                                         9.7                              1.0                                      2.9           1.0                 1.0          50.3         1.0                  
  **Had ever sex with regular sex partners in last year**                                                                                                                                                                       
   Yes                                                                        8.8                        0.1(0.1-0.6)\*\*          0.2(0.1-0.6)\*\*     3.6                                                                              
   No                                                                         42.9                             1.0                                      0.0                                                                              
  **Had ever sex with commercial sex partners in last year**                                                                                                                                                                    
   Yes                                                                        11.6                        1.7(1.0-2.7)\*            2.0(1.0-3.9)\*      3.1      0.7 (0.5-1.2)                                                           
   No                                                                         7.3                              1.0                        1.0           4.5           1.0                                                                
  **Ever received intervention**                                                                                                                                                                                                
   Yes                                                                        10.8                             1.0                                      3.8           1.0                              34.1         1.0                1.0
   No                                                                         9.3                          0.9(0.5-1.6)                                 3.7       1(0.4-2.6)                           53.8   2.3(1.4-3.7)\*\*    2.1(1.2-3.6)\*
  **HCV infection**                                                                                                                                                                                                                      
   Yes                                                                        36.7                      6.2(2.8-13.6)\*\*         12.1(4.1-20.3)\*\*                                                   42.9     0.9(0.4-1.9)             
   No                                                                         8.5                              1.0                        1.0                                                          45.4         1.0                  
  **Syphilis**                                                                                                                                                                                                                  
   Yes                                                                                                                                                  14.3   6.2(2.8-13.6)\*\*   8.0(3.5-18.0)\*\*   56.2   3.0(1.8-5.1)\*\*   4.2(2.4-7.4)\*\*
   No                                                                                                                                                   2.6           1.0                              27.9         1.0                1.0

OR: Odds ratio; AOR: Adjusted odds ratio, controlled factors included study sites, age, sex, residency, ethnicity, education, marital status, sexual behavior, HIV-related prevention services; CI: Confidence interval; NA: Not applicable; \* P \< 0.05; \*\* P \< 0.01.

Correlates for syphilis, HCV infection
--------------------------------------

Of the participants, 0.2% (n=2) were infected with HIV, 9.6% (n=77) with syphilis and 3.7% (n=30) with HCV. 1.4% (n=11) were infected with both syphilis and HCV. All syphilis cases (n=77) were methamphetamine users with 2 of them also ketamine and amphetamine users (Table  [1](#T1){ref-type="table"}). The participants infected with syphilis were more likely to be female, have ever had commercial sex in the past 12 months, be infected with HCV and less likely to have ever had sex with regular sex partners in the past 12 months. Participants infected with HCV were more likely to have ever injected drugs and be co-infected with syphilis (Table  [2](#T2){ref-type="table"}).

Discussion
==========

This is the first to report on the assessment of the syndemics of HIV, syphilis, HCV, and MA use among drug users in China. This study found alarmingly high rates of syphilis (9.6%), HCV infection (3.7%), and MA use (96.6%) among drug users in the two cities along the east coast of China with historically low HIV prevalence. Syphilis and HCV infection predicted each other, and being female was a common correlate for syphilis and unprotected sex. The findings of this study contribute to the understanding of the emergent role of club drug abuse on the HIV/syphilis epidemic and its association with risky sexual behavior in the two cities of Shandong Province.

This study showed that nearly 10% of participants were infected with syphilis, and all of them were MA users. The syphilis prevalence among drug users was significantly higher than that of female sex workers (3.07%), men who have sex with men (4.69%), pregnant women (0.33%) and unpaid blood donors (0.08%) in the same year. The logistic analysis revealed that syphilis was independently associated with ever having had unprotected sex with commercial sex partners in the past 12 months. Moreover, an alarmingly high prevalence (52.5%) of drug users self-reported ever having had sex with commercial sex partners, with 89.9% of these participants self-reporting inconsistent condom use in this study. MA use enhances sexual performance, sensitivity, and pleasure, resulting in a complexity of sexual partners and network, thereby increasing the risk of trauma from prolonged intercourse and failure to use condoms due to altered judgment and inhibition \[[@B21],[@B22]\]. It is even more worrisome that club drug users will take a potential role in the epidemiologic bridge of HIV/syphilis transmission to their regular sex partners \[[@B22]\]. This study also showed that club drug users had a low condom use rate with their regular sex partners. Trust in a sex partner or worrying suspicion ever having had commercial sex behavior by their regular sex partner resulted in low condom use with their regular sex partners. This indicates a great risk in transmission and/or acquisition of HIV/STDs within the club drug abuse and sex networks.

Results also showed participants who have ever had unprotected sex with commercial sex partners in the last sexual encounter were more likely to be female and the participants infected with syphilis were more likely to be female. Being female is the most vulnerable group for possible syphilis infection. In this study, of all participants, 17.8% (n=143) were female, among which 65.0% (n=93) reported having commercial sex. The syphilis prevalence was significantly higher among those females who have ever had commercial sex than those females who have never had commercial sex (22.5% VS. 8.0%). Our previous studies have shown the prevalence of syphilis infection increasing because of the club drug abuse among female sex workers (FSWs) in Qingdao \[[@B7]\]. However, the current intervention efforts are still focused on heroin, which played an important role in China's HIV/AIDS epidemic in the last decades, and the prevention infrastructure has not been strategized to tackle the newly emerging challenge of club drug abuse. In addition, this study also showed that only 4.7% of participants ever had a test for HIV while 52.6% knew their HIV test result, and 16.1% had received intervention in the past 12 months. A low number of HIV tests and HIV-related prevention services reflected the less intervention efforts targeted this group \[[@B1],[@B23]\], and the low practice of VCT still remains a challenge among targeted drug users. Unprotected heterosexual contacts has been increasing proportionally in contribution of HIV transmission in China, therefore it is possible that the club drug abuse could further fuel this trend in the nation if no better-targeted, effective intervention efforts are taken in a timely fashion \[[@B24]\].

Independent risk factors for HCV were injection drug users and co-infection with syphilis. According to this study, needle sharing of injection drug users could be a reasonable cause of the HCV infections. The findings underscore that harm reduction clear needle should be emphasized. Meanwhile, the high prevalence of syphilis demonstrated that a large number of drug users engaged in unprotected sex behaviors that may place them at high risk for HCV. HCV could be transmitted through parenteral exposures to contaminated blood, with efficiency through the use of injection drugs, e.g., sharing of needles or works \[[@B2],[@B3]\]. Studies have revealed that HCV risk increases commensurate with increasing numbers of heterosexual sex partners \[[@B25]\]. Studies have found that common factors for HCV were associated with group sex, accompanied by STDs, the use of club drugs and other non-injection drugs during sex \[[@B26],[@B27]\]. More research is needed to better understand the role of heterosexual transmission of HCV among this emerging group with a high risk for HIV and club drug use.

This study revealed that the prevalence of syphilis/HCV infection is alarmingly high and unprotected commercial sex was common among drug users. New types of drugs, especially MA, have become the predominant sources of drug abuse in these two cities in China. The findings of this study underscored the urgent need for comprehensive intervention strategies, including sex and drug-related interventions and HIV/syphilis/HCV control among this group. Methamphetamine is the predominant drug used among the drug users. We also should pay more attention to the intervention efforts to target syphilis prevention in FSWs, especially the drug using FSWs, and further research is needed to better understand the causal pathway of the syndemics, the driving forces for the high prevalence of syphilis, HCV, and MA use.

We recognized the limitations of this study. Data collection relying on retrospective self-reports was subject to recall bias. The sensitive nature of the questions (related to sexual and drug use behaviors) may have led to information bias due to the social desirability of certain answers. We didn't collect participants' sexual preference in this study. The cross-sectional nature of the data also makes it impossible to establish any causality. It may be another limitation that the non-response or refusal of participation during the recruitment process could reduce the representativeness of the study participants. Non-response could be substantial in this study because drug use is illegal in China. Information on study participation was lacking. Moreover, the recruitment criterion to complete the study may lead to a selection bias. Therefore, the results of this study might not fully generalizable to drug users in other settings in China or different countries. Despite these limitations and possible biases, we feel the data highlights a prevention opportunity that cannot be ignored.

Conclusions
===========

Synthetic drugs, especially methamphetamine, is the predominant drug used among the drug users in these two cities in China, the prevalence of syphilis and HCV infection are alarmingly high, and unprotected commercial sex was common among this group. The use of methamphetamine could fuel the epidemics of HIV, syphilis and other STDs in China. So far, no effective intervention programs are available targeting synthetic drug users in China. The findings highlight the need for effective, multifaceted interventions addressing sexual and drug use-related risky behaviors among this group. Further research is needed to better understand the causal pathway of the syndemics.
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